198
Views
2
CrossRef citations to date
0
Altmetric
Research Aricles

Circ_0072995 drives cervical cancer development by regulating the miR-29a/WDR5 axis

& ORCID Icon

References

  • Chaichian S, Shafabakhsh R, Mirhashemi SM, Moazzami B, Asemi Z. 2020. Circular RNAs: a novel biomarker for cervical cancer. Journal of Cellular Physiology 235:718–724.
  • Chen Y, Zhang W, Yan L, Zheng P, Li J. 2020. miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells. Peerj 8:e10148.
  • Ciaramella V, Sasso FC, Di Liello R, Corte C, Barra G, Viscardi G, et al. 2019. Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC. Journal of Experimental & Clinical Cancer Research 38:178.
  • Ding J, Wang Q, Guo N, Wang H, Chen H, Ni G, Li P. 2020. CircRNA circ_0072995 promotes the progression of epithelial ovarian cancer by modulating miR-147a/CDK6 axis. Aging 12:17209–17223.
  • Elasbali AM. 2021. Human papillomavirus: present and future perspective in Saudi Arabia. Journal of Obstetrics and Gynaecolog 41:497–502.
  • Geng A, Luo L, Ren F, Zhang L, Zhou H, Gao X. 2021. miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1. BMC Cancer 21:843.
  • Gu P, Chen X, Xie R, Han J, Xie W, Wang B, et al. 2017. lncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate cancer via recruiting WDR5. Molecular Therapy 25:1959–1973.
  • Guo J, Chen M, Ai G, Mao W, Li H, Zhou J. 2019. Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047. Biomedicine and Pharmacotherapy 115:108957.
  • He Q, Tao L, Xu H, Xie X, Cheng S. 2021. Circ_0072995 promotes proliferation and invasion via regulating miR-1253/EIF4A3 signaling in HCC. Cancer Management and Research 13:5981–5987.
  • Huang X, Luo Y, Li X. 2022. Circ_0072995 promotes ovarian cancer progression through regulating miR-122-5p/SLC1A5 axis. Biochemical Genetics 60:153–172.
  • Hulshoff MS, Del Monte-Nieto G, Kovacic J, Krenning G. 2019. Non-coding RNA in endothelial-to-mesenchymal transition. Cardiovascular Research 115:1716–1731.
  • Jiao J, Zhang T, Jiao X, Huang T, Zhao L, Ma D, Cui B. 2020. hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion. Journal of Cellular Physiology 235:1287–1295.
  • Li L, Wang ZX, Wang ZH. 2011. Combination of IL-24 and cisplatin inhibits cervical cancer growth in a xenograft nude mice model.  Asian Pacific Journal of Cancer Prevention 12:3293–3298.
  • Li Y, Li G, Guo X, Yao H, Wang G, Li C. 2020. Non-coding RNA in bladder cancer. Cancer Letters 485:38–44.
  • Liontos M, Kyriazoglou A, Dimitriadis I, Dimopoulos MA, Bamias A. 2019. Systemic therapy in cervical cancer: 30 years in review. Critical Reviews in Oncology/Hematology 137:9–17.
  • Liu J, Zhu H, Fu L, Xu T. 2021. Investigating the underlying mechanisms of circular RNAs and their application in clinical research of cervical cancer. Frontiers in Genetics 12:653051.
  • Liu Y, Yang Y, Wang Z, Fu X, Chu XM, Li Y, et al. 2020. Insights into the regulatory role of circRNA in angiogenesis and clinical implications. Atherosclerosis 298:14–26.
  • Lu C, Liu Z, Klement JD, Yang D, Merting AD, Poschel D, et al. 2021. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape. Journal for ImmunoTherapy of Cancer 9:e002624.
  • Lu K, Tao H, Si X, Chen Q. 2018. The histone H3 lysine 4 presenter WDR5 as an oncogenic protein and novel epigenetic target in cancer. Frontiers in Oncology 8:502.
  • Nan P, Niu Y, Wang X, Li Q. 2019. MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis. OncoTargets and Therapy 12:6917–6925.
  • Panni S, Lovering RC, Porras P, Orchard S. 2020. Non-coding RNA regulatory networks. Biochimica et Biophysica Acta. Gene Regulatory Mechanisms 1863:194417.
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 71:209–249.
  • Xue W, Yao X, Ting G, Ling J, Huimin L, Yuan Q, et al. 2021. BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis. Environmental Pollution (Barking, Essex : 1987) 268:115748.
  • Yi Y, Liu Y, Wu W, Wu K, Zhang W. 2019. Reconstruction and analysis of circRNA‑miRNA‑mRNA network in the pathology of cervical cancer. Oncol. Rep 41:2209–2225.
  • Zhang HD, Jiang LH, Hou JC, Zhou SY, Zhong SL, Zhu LP, et al. 2018. Circular RNA hsa_circ_0072995 promotes breast cancer cell migration and invasion through sponge for miR-30c-2-3p. Epigenomics 10:1229–1242.
  • Zhang J, Zhou Q, Xie K, Cheng L, Peng S, Xie R, et al. 2021. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer. Journal of Experimental & Clinical Cancer Research : CR 40:203.
  • Zhang W, Zhang S. 2020. Downregulation of circRNA_0000285 suppresses cervical cancer development by regulating miR197-3p-ELK1 axis. Cancer Management and Research 12:8663–8674.
  • Zou H, Chen H, Liu S, Gan X. 2021. Identification of a novel circ_0018289/miR-183-5p/TMED5 regulatory network in cervical cancer development. World Journal of Surgical Oncology 19:246.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.